Detalhe da pesquisa
1.
Canagliflozin alleviates pulmonary hypertension by activating PPARγ and inhibiting its S225 phosphorylation.
Acta Pharmacol Sin
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38719955
2.
Investigation of Metabolic and Inflammatory Disorder in the Aging FGF21 Knockout Mouse.
Inflammation
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38653921